SLC44A1 and familial pancreatic carcinoma: Isoquinoline derivatives Amb4269951 and Amb4269675, discovered through exploratory studies using a library of plant-derived natural organic compounds, are novel potential compounds for the treatment of pancreatic cancer with CTL1 inhibition.